Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
|Poll|March 29, 2016
Racing Heart, Chest Pain in a 65-year-old Man
Author(s)ReelDx
VIDEO: Palpitations persist in ED; no history of cardiac issues. Incident is first of its kind for this patient. Watch the interview.
Advertisement
Patient presents with "racing heart," weakness, mild chest pain. No history of similiar symptoms or of stroke, other cardiac issues. Denies ETOH, tobacco use. PMH: HTN; hyperlipidemia; chronic back pain. Current meds: lisinopril; hydrocodone/acetaminophen; simvastatin. Vitals: HR: 98 bpm, RR: 20, BP: 175/86; SpOâ: 98%.
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Advertisement
Advertisement
Trending on Patient Care Online
1
One Question PCPs Should Ask Every Patient with Atrial Fibrillation
2
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections
3
Evolocumab Tied to 20% Lower Risk of Myocardial Infarction vs Ezetimibe in Real-World Study
4
Setting Treatment Goals for Menopausal VMS and Sleep
5